Chemed (CHE) Stock Price Target 2026

The average analyst price target for Chemed is $603, 10.7% above the current price. Of 5 analysts, 3 rate it Buy and 2 Hold. Targets range from $510 to $675. The latest change came on Oct 29, 2026, when RBC Capital raised its price target on Chemed from $548 to $585 and kept a Sector Perform rating.

The Average Analyst Price Target for Chemed is $603.

Price Target Range — 11 Quarters

Analyst Consensus — 5 Analysts

3Buy

2Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$603Upside to Avg. PT+10.7%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Chemed Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 29, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$548→$585
Oct 29, 2026	UBS	A.J. Rice	PT Raise	Buy	$650→$675
Oct 29, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$590→$625
Oct 28, 2026	Jefferies	Brian Tanquilut	Upgrade	Hold→Buy	$520→$620
Sep 25, 2026	UBS	A.J. Rice	Initiate	Buy	$650
Jul 31, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$500→$590
Jul 30, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$436→$548
Jul 9, 2026	B of A Securities	Joanna Gajuk	PT Raise	Neutral	$450→$510
Apr 27, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$422→$436
Feb 27, 2026	RBC Capital	Ben Hendrix	Downgrade	Outperform→Sector Perform	$572→$422
Feb 27, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$580→$500
Jan 22, 2026	Jefferies	Brian Tanquilut	Downgrade	Buy→Hold	$550→$475
Nov 10, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$589→$572
Sep 10, 2025	B of A Securities	Joanna Gajuk	PT Cut	Buy	$610→$595
Sep 2, 2025	Jefferies	Brian Tanquilut	Upgrade	Hold→Buy	$490→$550
Jul 31, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$640→$589
Jul 31, 2025	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$650→$580
Jul 25, 2025	Jefferies	Brian Tanquilut	Initiate	Hold	$500
Jun 30, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$674→$640
Jun 30, 2025	B of A Securities	Joanna Gajuk	PT Cut	Buy	$708→$650